Incyte Stock: Is INCY Outperforming the Healthcare Sector?

Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise?

Should Insmed’s (INSM) NASDAQ-100 Exit and TPIP Focus Require Action From Investors?

Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global Respiratory

Kymera Therapeutics (KYMR) Soars 10.0%: Is Further Upside Left in the Stock?

Nebius and CoreWeave fall after Nasdaq 100 listing

EMBARC Announces Its Intention to Collaborate with Insmed on Landmark Interventional Study Evaluating Disease Modification Potential of Brensocatib in Bronchiectasis

Mizuho Maintains an Outperform Rating on Insmed Incorporated (INSM)

Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors

Here’s Why TimesSquare Mid Cap Growth Strategy Added Insmed (INSM)